Rashe Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
as on 03-01-2025
- Paid Up Capital ₹ 0.10 M
as on 03-01-2025
- Company Age 5 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 339.34%
(FY 2022)
- Profit 19.77%
(FY 2022)
- Ebitda 18.97%
(FY 2022)
- Net Worth -25.81%
(FY 2022)
- Total Assets -52.99%
(FY 2022)
About Rashe Lifesciences
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shekappa and Rajesh Ramachandra serve as directors at the Company.
- CIN/LLPIN
U52599KA2019PTC123669
- Company No.
123669
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Apr 2019
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Rashe Lifesciences Private Limited offer?
Rashe Lifesciences Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Antacid Drugs, Common Disease Medicines, Pharmaceutical Capsules, Sexual Wellness Products, Erectile Dysfunction Medicine, Anti Infective Drugs & Medicines, Antifungal Injection, Tablet & Syrup, Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines.
Who are the key members and board of directors at Rashe Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shekappa  | Director | 23-Apr-2019 | Current |
| Rajesh Ramachandra | Director | 23-Apr-2019 | Current |
Financial Performance of Rashe Lifesciences.
Rashe Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 339.34% increase. The company also saw a substantial improvement in profitability, with a 19.77% increase in profit. The company's net worth observed a substantial decline by a decrease of 25.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rashe Lifesciences?
Unlock access to Rashe Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rashe Lifesciences?
Unlock and access historical data on people associated with Rashe Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rashe Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rashe Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
